PortfoliosLab logoPortfoliosLab logo
OGC.TO vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OGC.TO vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in OceanaGold Corporation (OGC.TO) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

OGC.TO is traded in CAD, while TGTX is traded in USD. To make them comparable, the TGTX values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, OGC.TO achieves a -9.52% return, which is significantly lower than TGTX's 98.16% return. Over the past 10 years, OGC.TO has underperformed TGTX with an annualized return of 8.68%, while TGTX has yielded a comparatively higher 25.82% annualized return.


OGC.TO

1D
-0.65%
1M
-0.51%
6M
-16.65%
YTD
-9.52%
1Y
80.78%
3Y*
65.79%
5Y*
38.13%
10Y*
8.68%

TGTX

1D
-3.32%
1M
20.71%
6M
104.95%
YTD
98.16%
1Y
59.73%
3Y*
33.87%
5Y*
9.87%
10Y*
25.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OGC.TO vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OGC.TO
OceanaGold Corporation
-9.52%227.48%57.16%-1.22%17.27%-10.57%-3.53%-48.74%54.71%-17.19%
TGTX
TG Therapeutics, Inc.
98.16%-5.48%91.15%40.94%-33.79%-63.49%357.53%159.57%-45.80%64.40%

Correlation

The correlation between OGC.TO and TGTX is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.04

Fundamentals

Market Cap

OGC.TO:

CA$7.83B

TGTX:

$8.74B

EPS

OGC.TO:

$1.94

TGTX:

$2.88

PE Ratio

OGC.TO:

12.74

TGTX:

19.80

PEG Ratio

OGC.TO:

0.03

TGTX:

0.03

PS Ratio

OGC.TO:

4.30

TGTX:

13.06

PB Ratio

OGC.TO:

2.34

TGTX:

15.68

Total Revenue (TTM)

OGC.TO:

$2.25B

TGTX:

$700.35M

Gross Profit (TTM)

OGC.TO:

$1.24B

TGTX:

$581.54M

EBITDA (TTM)

OGC.TO:

$1.22B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OGC.TO vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OGC.TO
OGC.TO Risk / Return Rank: 8181
Overall Rank
OGC.TO Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
OGC.TO Sortino Ratio Rank: 8080
Sortino Ratio Rank
OGC.TO Omega Ratio Rank: 7979
Omega Ratio Rank
OGC.TO Calmar Ratio Rank: 7979
Calmar Ratio Rank
OGC.TO Martin Ratio Rank: 7878
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 7575
Overall Rank
TGTX Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 7575
Sortino Ratio Rank
TGTX Omega Ratio Rank: 7575
Omega Ratio Rank
TGTX Calmar Ratio Rank: 7474
Calmar Ratio Rank
TGTX Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OGC.TO vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for OceanaGold Corporation (OGC.TO) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OGC.TOTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.40

Sortino ratioReturn per unit of downside risk

+0.17

Omega ratioGain probability vs. loss probability

1.26

1.24

+0.02

Calmar ratioReturn relative to maximum drawdown

1.98

1.77

+0.21

Martin ratioReturn relative to average drawdown

4.65

3.27

+1.38

OGC.TO vs. TGTX - Sharpe Ratio Comparison

The current OGC.TO Sharpe Ratio is 1.60, which is higher than the TGTX Sharpe Ratio of 1.20. The chart below compares the historical Sharpe Ratios of OGC.TO and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OGC.TO vs. TGTX - Drawdown Comparison

The maximum OGC.TO drawdown since its inception was -96.53%, roughly equal to the maximum TGTX drawdown of -99.53%. Use the drawdown chart below to compare losses from any high point for OGC.TO and TGTX.


Loading charts...

Drawdown Indicators


OGC.TOTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-96.53%

-99.53%

+3.00%

Max Drawdown (1Y)

Largest decline over 1 year

-42.13%

-32.35%

-9.78%

Max Drawdown (3Y)

Largest decline over 3 years

-42.13%

-68.41%

+26.28%

Max Drawdown (5Y)

Largest decline over 5 years

-46.87%

-90.05%

+43.18%

Max Drawdown (10Y)

Largest decline over 10 years

-76.17%

-93.15%

+16.98%

Current Drawdown

Current decline from peak

-39.54%

-66.37%

+26.83%

Average Drawdown

Average peak-to-trough decline

-40.05%

-89.81%

+49.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.88%

17.48%

+0.40%

Volatility

OGC.TO vs. TGTX - Volatility Comparison

OceanaGold Corporation (OGC.TO) has a higher volatility of 15.11% compared to TG Therapeutics, Inc. (TGTX) at 12.26%. This indicates that OGC.TO's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OGC.TOTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.11%

12.26%

+2.85%

Volatility (6M)

Calculated over the trailing 6-month period

42.03%

34.65%

+7.38%

Volatility (1Y)

Calculated over the trailing 1-year period

51.98%

47.77%

+4.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.00%

88.35%

-38.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.57%

87.33%

-34.76%

Dividends

OGC.TO vs. TGTX - Dividend Comparison

OGC.TO's dividend yield for the trailing twelve months is around 0.94%, while TGTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
OGC.TO
OceanaGold Corporation
0.94%0.29%0.23%0.36%0.00%0.00%0.00%0.18%0.26%0.27%0.46%0.63%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

OGC.TO vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between OceanaGold Corporation and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
702.79M
204.92M
(OGC.TO) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

OGC.TO vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between OceanaGold Corporation and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
56.5%
83.7%
Portfolio components
OGC.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported a gross profit of 397.08M and revenue of 702.79M. Therefore, the gross margin over that period was 56.5%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

OGC.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported an operating income of 330.79M and revenue of 702.79M, resulting in an operating margin of 47.1%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

OGC.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, OceanaGold Corporation reported a net income of 224.66M and revenue of 702.79M, resulting in a net margin of 32.0%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


OGC.TO and TGTX have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for OGC.TO and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer